Found 0 matching trials
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) PHASE1 The primary objective of the study is to assess the safety and tolerability...
Show More Location
Azienda Ospedaliero Universitaria Careggi
Learn More & Join Trial
Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma PHASE1 The primary objective of the study is to assess the safety and tolerability...
Show More Location
Byers Eye Institute at Stanford University
Learn More & Join Trial
Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study) PHASE3 Primary objectives
* To compare the efficacy of cenegermin vs vehicle in S...
Show More Location
Lugene Eye Institute - Glendale Office
Learn More & Join Trial
Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study NA This pilot study evaluates the feasibility and outcomes of two treatment ap...
Show More Location
Ivey Eye Institute, St. Joseph's Health Care London
Learn More & Join Trial
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye PHASE2 The primary objective of this study was to assess the efficacy and safety o...
Show More Location
Penn Dry Eye and Ocular Surface Center, University of Pennsylvania
Learn More & Join Trial
DOMPE -MT Neurotrophic Keratitis PHASE4 TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatmen...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Location
Covance Basel Research Unit AG - Lettenweg 118 -
Learn More & Join Trial
An 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotrophic Keratopathy Treated With Recombinant Human Nerve Growth Factor (rhNGF) Eyedrops N/A A prospective, longitudinal, cross-sectional, observational Study with a 8-...
Show More Location
Ophtalmology Clinic, G.d'Annunzio University
Learn More & Join Trial
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease. PHASE2 Primary objective
• To evaluate the efficacy of 5 μg/mL and 10 μg/mL conce...
Show More Location
Arizona Eye Center
Learn More & Join Trial
DEFENDO Long Term Follow-up Study in Stage 1 NK Patients N/A Primary Objective
To evaluate the long-term safety and efficacy (healing) ...
Show More Location
New Vision Institute
Learn More & Join Trial